Unknown

Dataset Information

0

A prognostic model for hepatitis B acute-on-chronic liver failure patients treated using a plasma exchange-centered liver support system.


ABSTRACT: AIM:To determine the prognostic risk factors of patients with hepatitis B virus related acute-on-chronic liver failure (HBV-ACLF) treated with plasma exchange (PE)-based artificial liver support system (ALSS), and create a prognostic predictive model. METHODS:A total of 304 HBV-ACLF patients who received PE-based ALSS were retrospectively analyzed. Potential prognostic factors on admission associated with survival were investigated. Of note, 101 additional patients were analyzed to validate the performance of the prognostic models. RESULTS:According to 28-day survival, a total of 207 patients who survived and 97 non-survivors were identified in the derivation group. Overall, 268 (88.2%) ACLF cases were caused by reactivation of HBV. Cox proportional hazards regression model revealed that age, total bilirubin, ln (alpha-fetoprotein [AFP]), encephalopathy (HE) score, sodium level, and international normalized ratio (INR) were independent risk factors of short-term prognosis. We built a model named ALSS-prognosis model (APM) to predict the 28-day survival of HBV-ACLF patients with ALSS; the model APM showed potentially better predictive performance for both the derivation and validation groups than MELD, MELD-Na, and CLIF-C ACLF score. CONCLUSIONS:Low AFP was found to be an independent risk factor for high mortality in HBV-ACLF patients treated with PE-based ALSS. We generated a new model containing AFP, namely APM, which showed potentially better prediction performance than MELD, MELD-Na, and CLIF-C ACLF score for short-term outcomes, and could aid physicians in making optimal therapeutic decisions.

SUBMITTER: Xie Z 

PROVIDER: S-EPMC7217207 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

A prognostic model for hepatitis B acute-on-chronic liver failure patients treated using a plasma exchange-centered liver support system.

Xie Zhongyang Z   Violetta Laurencia L   Chen Ermei E   Huang Kaizhou K   Wu Daxian D   Xu Xiaowei X   Ouyang Xiaoxi X   Zhao Yalei Y   Li Lanjuan L  

Journal of clinical apheresis 20191126 2


<h4>Aim</h4>To determine the prognostic risk factors of patients with hepatitis B virus related acute-on-chronic liver failure (HBV-ACLF) treated with plasma exchange (PE)-based artificial liver support system (ALSS), and create a prognostic predictive model.<h4>Methods</h4>A total of 304 HBV-ACLF patients who received PE-based ALSS were retrospectively analyzed. Potential prognostic factors on admission associated with survival were investigated. Of note, 101 additional patients were analyzed t  ...[more]

Similar Datasets

| S-EPMC7809456 | biostudies-literature
| S-EPMC8635207 | biostudies-literature
| S-EPMC5398520 | biostudies-literature
| S-EPMC6848208 | biostudies-literature
2018-10-23 | PXD007975 | Pride
| S-EPMC8355541 | biostudies-literature
| S-EPMC7005653 | biostudies-literature
| S-EPMC7422541 | biostudies-literature
| S-EPMC5724358 | biostudies-literature
| S-EPMC4364698 | biostudies-literature